COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood

AIM: Increased cardiovascular risk after use of selective or nonselective cyclooxygenase-2 (COX-2)-inhibitors might partly be caused by enhanced platelet aggregability. However, an effect of COX-2 inhibition on platelets has so far not been observed in humans. METHODS: We tested in healthy volunteer...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgdorff, Piet, Handoko, M. Louis, Wong, Yeun Ying, Tangelder, Geert Jan
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040455/
https://www.ncbi.nlm.nih.gov/pubmed/21331307
http://dx.doi.org/10.2174/1874192401004010198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040455/
https://www.ncbi.nlm.nih.gov/pubmed/21331307
http://dx.doi.org/10.2174/1874192401004010198

Ejemplares similares